Sign In
Buy DXR
$10.50
-0.345 (-3.18%)
At Close: Jul 31, 2026
Daxor Corporation (DXR) Q2 2022 Earnings Call Transcript
07:06pm, Friday, 26'th Aug 2022
Daxor Corporation (NASDAQ:DXR ) Q2 2022 Earnings Conference Call August 25, 2022 4:30 PM ET Company Participants Scott Gordon - President and Co-Founder of CORE IR Michael Feldschuh - CEO & President
Daxor Corporation Reports a 92.6 Percent Revenue Increase in Diagnostic Operating Division in Form N-CSR Filing for the Six Months Ended June 30, 2022
08:05pm, Thursday, 25'th Aug 2022 GlobeNewswire Inc.
Conference Call to be held today at 4:30 p.m. Eastern Time
Daxor Corporation to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update
08:40pm, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.
Conference Call to be held on the same day at 4:30 p.m. Eastern Time
Daxor Corporation to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update
04:40pm, Wednesday, 24'th Aug 2022
Conference Call to be held on the same day at 4:30 p.m. Eastern Time
Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Conference
08:00am, Thursday, 12'th May 2022
NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will pres
Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference
12:00pm, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
Oak Ridge, TN, March 23, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces that President and CEO Michael Feldschuh will p
Daxor reports FY results (NASDAQ:DXR)
02:15pm, Tuesday, 01'st Mar 2022 Seeking Alpha
Daxor press release (DXR): FY NAV of $5.24 per share versus $3.89 in FY 2020.
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Assessment of Heart Failure
01:00pm, Thursday, 17'th Feb 2022 GlobeNewswire
Daxor ’s BVA-100 ® Shown to Provide Unique and Actionable Data for Addressing Heart Failure
Daxor Corporation Commences Trading on The NASDAQ Capital Market
01:00pm, Wednesday, 02'nd Feb 2022 GlobeNewswire Inc.
Management to Ring the Nasdaq Stock Market Opening Bell on February 4, 2022
Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors
01:00pm, Friday, 21'st Jan 2022 GlobeNewswire Inc.
Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announced today that it has appointed Caleb DesRosiers, JD,
Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022
09:05pm, Thursday, 20'th Jan 2022 GlobeNewswire Inc.
Oak Ridge, TN, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
01:00pm, Thursday, 06'th Jan 2022 GlobeNewswire Inc.
Oak Ridge, TN, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh wil
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
08:00am, Thursday, 06'th Jan 2022
Oak Ridge, TN, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will
DAXOR AWARDED NEW PATENT FOR BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES
01:00pm, Tuesday, 04'th Jan 2022 GlobeNewswire Inc.
Method Patent Covers Blood Volume Analysis Technology to Evaluate and Guide Treatment Decisions in Multiple Medical Conditions
Daxor Corporation Receives $200K Matching Fund Award from Launch Tennessee
08:30am, Friday, 01'st Oct 2021
The SBIR/STTR Matching Fund Grant Will Advance the Company's Innovation and Commercialization Efforts, and Job Creation
